EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 12.0% of their position (11K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $2.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/17/2026ACC: 0001493152-26-043073
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+11K
Net shares
Net buyer
$2.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11K
Price / share
$0.21
Trade value
$2.31K
% of position
12.0%
9/16/2026
91.82K→102.82K
Total
Net shares
+11K
Net value
$2.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2026 | P · Purchase | +11K | $0.21 | $2.31K | 12.0% | 91.82K | 102.82K |
| Total | +11K | $2.31K | ||||||
Derivative Transactions0
No derivative transactions reported